Sinopharm Capital
Overview
Sinopharm Capital is a private equity and venture capital investment firm founded in 2012 that specializes in the healthcare, life sciences, and biotechnology sectors in China.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Ancare Medical | Feb 2018 | Pre Seed | Lead |
| Skynor Medical | Jan 2019 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Sinopharm Capital based?
Sinopharm Capital is headquartered in Shanghai, China.
When was Sinopharm Capital founded?
Sinopharm Capital was founded in 2012.
How many portfolio companies does Sinopharm Capital have?
Sinopharm Capital has 2 portfolio companies in Caplight's dataset.
What are some companies in Sinopharm Capital's portfolio?
Portfolio companies visible on Caplight include Ancare Medical, Skynor Medical.
What was Sinopharm Capital's most recent investment shown here?
Sinopharm Capital's most recent investment in this portfolio sample was in Skynor Medical in 2019.
What sectors does Sinopharm Capital focus on?
Sinopharm Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences.
What company stages does Sinopharm Capital focus on?
Sinopharm Capital typically invests at the Early stage.
What is Sinopharm Capital's AUM?
Sinopharm Capital's assets under management are estimated between $942.0M and $985.5M.